Bryan T Mott

Author PubWeight™ 17.07‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell-like diffuse large B-cell lymphoma cells. Proc Natl Acad Sci U S A 2014 2.50
2 Comparison of raltegravir and elvitegravir on HIV-1 integrase catalytic reactions and on a series of drug-resistant integrase mutants. Biochemistry 2008 1.82
3 Quantitative high-throughput screening identifies 8-hydroxyquinolines as cell-active histone demethylase inhibitors. PLoS One 2010 1.71
4 Complementarity between a docking and a high-throughput screen in discovering new cruzain inhibitors. J Med Chem 2010 1.54
5 Quantitative analyses of aggregation, autofluorescence, and reactivity artifacts in a screen for inhibitors of a thiol protease. J Med Chem 2010 1.45
6 Comparison of bioluminescent kinase assays using substrate depletion and product formation. Assay Drug Dev Technol 2009 1.04
7 An artemisinin-derived dimer has highly potent anti-cytomegalovirus (CMV) and anti-cancer activities. PLoS One 2011 1.00
8 Thiazole, oxadiazole, and carboxamide derivatives of artemisinin are highly selective and potent inhibitors of Toxoplasma gondii. J Med Chem 2010 0.91
9 Potent and selective small molecule inhibitors of specific isoforms of Cdc2-like kinases (Clk) and dual specificity tyrosine-phosphorylation-regulated kinases (Dyrk). Bioorg Med Chem Lett 2011 0.89
10 Malaria-infected mice are completely cured by one 6 mg/kg oral dose of a new monomeric trioxane sulfide combined with mefloquine. J Med Chem 2011 0.85
11 A cell-permeable ester derivative of the JmjC histone demethylase inhibitor IOX1. ChemMedChem 2014 0.83
12 Unique and highly selective anticytomegalovirus activities of artemisinin-derived dimer diphenyl phosphate stem from combination of dimer unit and a diphenyl phosphate moiety. Antimicrob Agents Chemother 2013 0.80
13 In vitro screening of compounds against laboratory and field isolates of human hookworm reveals quantitative differences in anthelmintic susceptibility. Am J Trop Med Hyg 2013 0.79
14 A three-dimensional in silico pharmacophore model for inhibition of Plasmodium falciparum cyclin-dependent kinases and discovery of different classes of novel Pfmrk specific inhibitors. J Med Chem 2004 0.78
15 High-throughput screen identifies cyclic nucleotide analogs that inhibit prostatic acid phosphatase. J Biomol Screen 2012 0.75
16 Personalized medicine: changing the paradigm of drug development. Methods Mol Biol 2012 0.75